BrokerLens

Advanced Enzyme Technologies Limited IPO (ADVENZYMES)

Status
Listed
Security type
Mainboard
Price band
Rs 880 to Rs 896
Final issue price
Rs 896
Issue size
Not disclosed
Bidding opens
20 July 2016
Bidding closes
22 July 2016
Listing date
1 August 2016

Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.

Sponsored
Zerodha

Brokerage-free equity & mutual fund investments

Trade with Zerodha's Kite platform and tools.

  • Zero brokerage on equity delivery
  • ₹20 flat for intraday, F&O, currency and commodity*
  • Free direct mutual fund investing
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. Full disclaimer at zerodha.com/pricing. Member ID NSE (13906), BSE (6498), MCX (46025).
Sponsored
5paisa

Flat ₹20 per order, every segment

Trade stocks, derivatives and more on 5paisa's platform.

  • ₹20 flat for delivery, intraday and F&O
  • Free account opening
  • Listed on NSE and BSE
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. SEBI Registration: INZ000010231.

Frequently asked questions

What is the price band for the Advanced Enzyme Technologies Limited IPO?

The Advanced Enzyme Technologies Limited IPO price band is Rs 880 to Rs 896 per share.

When does the Advanced Enzyme Technologies Limited IPO open and close?

Bidding opens 20 July 2016 and closes 22 July 2016.

Is the Advanced Enzyme Technologies Limited IPO a mainboard or SME issue?

Advanced Enzyme Technologies Limited is a mainboard IPO, listing on NSE's main board.

When did the Advanced Enzyme Technologies Limited IPO list?

Advanced Enzyme Technologies Limited listed on 1 August 2016.

Does this page show the grey market premium (GMP) for Advanced Enzyme Technologies Limited?

No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.

Is investing in the Advanced Enzyme Technologies Limited IPO recommended by BrokerLens?

No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.